CO5631437A2 - Parecoxib sodico cristalino - Google Patents
Parecoxib sodico cristalinoInfo
- Publication number
- CO5631437A2 CO5631437A2 CO04090186A CO04090186A CO5631437A2 CO 5631437 A2 CO5631437 A2 CO 5631437A2 CO 04090186 A CO04090186 A CO 04090186A CO 04090186 A CO04090186 A CO 04090186A CO 5631437 A2 CO5631437 A2 CO 5631437A2
- Authority
- CO
- Colombia
- Prior art keywords
- parecoxib
- sodium
- accordance
- sodico
- cristalino
- Prior art date
Links
- 229960004662 parecoxib Drugs 0.000 title abstract 5
- TZRHLKRLEZJVIJ-UHFFFAOYSA-N parecoxib Chemical compound C1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C1=C(C)ON=C1C1=CC=CC=C1 TZRHLKRLEZJVIJ-UHFFFAOYSA-N 0.000 title abstract 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 4
- 229910052708 sodium Inorganic materials 0.000 abstract 4
- 239000011734 sodium Substances 0.000 abstract 4
- 238000001157 Fourier transform infrared spectrum Methods 0.000 abstract 1
- 238000000113 differential scanning calorimetry Methods 0.000 abstract 1
- 229960003925 parecoxib sodium Drugs 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 238000000634 powder X-ray diffraction Methods 0.000 abstract 1
- 238000001757 thermogravimetry curve Methods 0.000 abstract 1
- ICJGKYTXBRDUMV-UHFFFAOYSA-N trichloro(6-trichlorosilylhexyl)silane Chemical compound Cl[Si](Cl)(Cl)CCCCCC[Si](Cl)(Cl)Cl ICJGKYTXBRDUMV-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36456702P | 2002-03-15 | 2002-03-15 | |
| US41798702P | 2002-10-11 | 2002-10-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5631437A2 true CO5631437A2 (es) | 2006-04-28 |
Family
ID=28045416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO04090186A CO5631437A2 (es) | 2002-03-15 | 2004-09-10 | Parecoxib sodico cristalino |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20030232871A1 (enExample) |
| EP (1) | EP1485362A1 (enExample) |
| JP (1) | JP2005529084A (enExample) |
| KR (1) | KR100763045B1 (enExample) |
| CN (1) | CN1642926A (enExample) |
| AR (1) | AR038985A1 (enExample) |
| AU (1) | AU2003220180A1 (enExample) |
| BR (1) | BR0308431A (enExample) |
| CA (1) | CA2478500A1 (enExample) |
| CO (1) | CO5631437A2 (enExample) |
| IL (1) | IL163780A0 (enExample) |
| MX (1) | MXPA04008932A (enExample) |
| MY (1) | MY148518A (enExample) |
| NZ (1) | NZ535951A (enExample) |
| PL (1) | PL372880A1 (enExample) |
| RU (1) | RU2300529C2 (enExample) |
| TW (1) | TW200400949A (enExample) |
| WO (1) | WO2003078408A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050143431A1 (en) * | 2003-04-04 | 2005-06-30 | Hetero Drugs Limited | Novel crystalline forms of parecoxib sodium |
| JP2007507538A (ja) | 2003-10-02 | 2007-03-29 | エラン ファーマシューティカルズ，インコーポレイテッド | 疼痛軽減方法 |
| JP2007517013A (ja) * | 2003-12-24 | 2007-06-28 | ファルマシア コーポレーション | 炎症、疼痛および／または発熱の治療を目的としたｃｏｘ−２阻害薬バルデコキシブのプロドラッグとしてのパレコキシブ金属塩 |
| ITMI20040019A1 (it) * | 2004-01-12 | 2004-04-12 | Univ Bari | Derivati isossazolici e loro impiego come inibitori della ciclossigenasi |
| US7796785B2 (en) * | 2005-03-03 | 2010-09-14 | Fujifilm Corporation | Image extracting apparatus, image extracting method, and image extracting program |
| US20080108664A1 (en) * | 2005-12-23 | 2008-05-08 | Liu Belle B | Solid-state form of AMG 706 and pharmaceutical compositions thereof |
| US7989450B2 (en) | 2008-01-11 | 2011-08-02 | Universita' Degli Studi Di Bari | Functionalized diarylisoxazoles inhibitors of ciclooxygenase |
| GB0919757D0 (en) * | 2009-11-12 | 2009-12-30 | Johnson Matthey Plc | Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs |
| US8299295B2 (en) | 2009-10-15 | 2012-10-30 | Johnson Matthey Public Limited Company | Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs |
| CN105726496B (zh) * | 2014-12-12 | 2019-05-28 | 湖南科伦药物研究有限公司 | 一种帕瑞昔布钠冻干粉剂、其制备方法及其粉剂产品 |
| CN105125506A (zh) * | 2015-08-18 | 2015-12-09 | 上海秀新臣邦医药科技有限公司 | 一种注射用帕瑞昔布钠及其制备方法 |
| CN106580893A (zh) * | 2016-12-26 | 2017-04-26 | 上药东英（江苏）药业有限公司 | 一种帕瑞昔布钠冻干粉针制剂 |
| CN106692079A (zh) * | 2016-12-26 | 2017-05-24 | 上药东英（江苏）药业有限公司 | 一种帕瑞昔布钠长效冻干粉针制剂 |
| CN117003769B (zh) * | 2023-07-11 | 2024-11-22 | 中国科学院宁波材料技术与工程研究所 | 氯诺昔康复合物、氯诺昔康-小檗碱共晶及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1288206B1 (en) * | 1996-04-12 | 2008-09-17 | G.D. Searle LLC | Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors |
| CN100558356C (zh) * | 1996-10-15 | 2009-11-11 | G.D.瑟尔公司 | 应用环加氧酶-2抑制剂治疗和预防肿瘤形成的方法 |
| PE20021017A1 (es) * | 2001-04-03 | 2002-11-24 | Pharmacia Corp | Composicion parenteral reconstituible |
| IL161086A0 (en) * | 2001-10-02 | 2004-08-31 | Pharmacia Corp | Method for preparing benzenesulfonyl compounds |
-
2003
- 2003-03-12 KR KR1020047014454A patent/KR100763045B1/ko not_active Expired - Fee Related
- 2003-03-12 CN CNA038060884A patent/CN1642926A/zh active Pending
- 2003-03-12 RU RU2004127585/04A patent/RU2300529C2/ru not_active IP Right Cessation
- 2003-03-12 WO PCT/US2003/007484 patent/WO2003078408A1/en not_active Ceased
- 2003-03-12 MX MXPA04008932A patent/MXPA04008932A/es unknown
- 2003-03-12 JP JP2003576414A patent/JP2005529084A/ja active Pending
- 2003-03-12 PL PL03372880A patent/PL372880A1/xx not_active Application Discontinuation
- 2003-03-12 EP EP03716476A patent/EP1485362A1/en not_active Withdrawn
- 2003-03-12 CA CA002478500A patent/CA2478500A1/en not_active Abandoned
- 2003-03-12 BR BR0308431-0A patent/BR0308431A/pt not_active IP Right Cessation
- 2003-03-12 US US10/387,173 patent/US20030232871A1/en not_active Abandoned
- 2003-03-12 IL IL16378003A patent/IL163780A0/xx unknown
- 2003-03-12 AU AU2003220180A patent/AU2003220180A1/en not_active Abandoned
- 2003-03-12 NZ NZ535951A patent/NZ535951A/en unknown
- 2003-03-14 TW TW092105693A patent/TW200400949A/zh unknown
- 2003-03-14 MY MYPI20030900A patent/MY148518A/en unknown
- 2003-03-14 AR ARP030100915A patent/AR038985A1/es unknown
-
2004
- 2004-09-10 CO CO04090186A patent/CO5631437A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL372880A1 (en) | 2005-08-08 |
| JP2005529084A (ja) | 2005-09-29 |
| RU2300529C2 (ru) | 2007-06-10 |
| EP1485362A1 (en) | 2004-12-15 |
| KR100763045B1 (ko) | 2007-10-04 |
| CA2478500A1 (en) | 2003-09-25 |
| KR20040095288A (ko) | 2004-11-12 |
| RU2004127585A (ru) | 2005-04-10 |
| MXPA04008932A (es) | 2004-11-26 |
| US20030232871A1 (en) | 2003-12-18 |
| AU2003220180A1 (en) | 2003-09-29 |
| AR038985A1 (es) | 2005-02-02 |
| NZ535951A (en) | 2006-02-24 |
| CN1642926A (zh) | 2005-07-20 |
| IL163780A0 (en) | 2005-12-18 |
| WO2003078408A1 (en) | 2003-09-25 |
| MY148518A (en) | 2013-04-30 |
| BR0308431A (pt) | 2005-01-18 |
| TW200400949A (en) | 2004-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5631437A2 (es) | Parecoxib sodico cristalino | |
| EP1126849A4 (en) | HETEROCYCLIC POTASSIUM CHANNEL INHIBITORS | |
| ATE423557T1 (de) | Carbocyclische kaliumkanalhemmer | |
| CY1106870T1 (el) | Σταθεροποιηση ραπαμυκινης ή παραγωγων ραπαμυκινης | |
| UA39099C2 (uk) | Циклічні азотовмісні похідні, суміш їх ізомерів або окремі ізомери, або їх солі | |
| HRP20020429B1 (en) | Polymorphic form of atorvastatin calcium | |
| ATE299890T1 (de) | Inhibitoren von gamma-secretase | |
| MY139235A (en) | One step process for the preparation of anticonvulsant derivatives | |
| BR9908701B1 (pt) | produto oral para remineralizar dentes. | |
| SE0101108D0 (sv) | A quaternary ammonium alkyl hydroxyethyl cellulose ether as a conditioner for hair and skin | |
| SI1410791T1 (sl) | Peroralna galenska oblika, ki obsega metformin insredstvo za pospeĺ evanje absorpcije | |
| MX2024012348A (es) | Forma cristalina de lanifibranor | |
| CO4970820A1 (es) | Sal de bisulfato del inhibidor de la vih-proteasa | |
| ATE215978T1 (de) | Talkum enthaltende polypropylenzusammensetzungen | |
| DE69928655D1 (de) | Substituierte porphyrine | |
| ES2167992T3 (es) | Composicion de maquillaje que comprende una poli-alfa-olefina. | |
| DE59103664D1 (de) | Verfahren zur Inhibierung und Zerstörung von Peroxiden in Dialkylethern. | |
| FI973221A0 (fi) | 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina | |
| DE69130326D1 (de) | Piperidin-verbindungen, ihre darstellung und ihre verwendung | |
| DE60129804D1 (de) | Hydrophobierende mikro-emulsionen | |
| HUP0000362A2 (hu) | Madár-reovírusok új antigén osztálya | |
| ATE390134T1 (de) | (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4- fluorophenyl)ethyl)-4-piperidinemethanol oder prodrug davon zur behandlung von demenzsymptomen oder kognitiven störungen | |
| ATE305472T1 (de) | Dibenzodiazepin derivate, deren herstellung und verwendung | |
| NO20024016D0 (no) | Svingdör | |
| ATE408697T1 (de) | Enzymatische umwandlung von gdp-mannose in gdp- fucose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |